All Stories

  1. Iodine Absorption in Celiac Children: A Longitudinal Pilot Study
  2. Trends of Liver Stiffness in Inflammatory Bowel Disease with Chronic Hepatitis C
  3. Chronic Viral Hepatitis in a Cohort of Inflammatory Bowel Disease Patients from Southern Italy: A Case-Control Study
  4. Advances in understanding the potential therapeutic applications of gut microbiota and probiotic mediated therapies in celiac disease
  5. Soy Metabolism by Gut Microbiota from Patients with Precancerous Intestinal Lesions
  6. Evaluation of Non-Celiac Gluten Sensitivity in Patients with Previous Diagnosis of Irritable Bowel Syndrome: A Randomized Double-Blind Placebo-Controlled Crossover Trial
  7. Gut Microbiota Imbalance is Related to Sporadic Colorectal Neoplasms. A Pilot Study
  8. Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease
  9. Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement
  10. Phytoestrogens: Dietary Intake, Bioavailability, and Protective Mechanisms against Colorectal Neoproliferative Lesions
  11. The Spectrum of Small Intestinal Lesions in Patients with Unexplained Iron Deficiency Anemia Detected by Video Capsule Endoscopy
  12. Can the Antisecretory Factor Be Considered a New Therapy for the Short Bowel Syndrome?
  13. Predictivity of Autoimmune Stigmata for Gluten Sensitivity in Subjects with Microscopic Enteritis: A Retrospective Study
  14. Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors
  15. Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapy
  16. Is the use of the BMI alone sufficient to diagnose malnutrition in both male and female adults?
  17. Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials
  18. Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis
  19. Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm
  20. Histamine and Histaminergic Receptors in Colorectal Cancer: From Basic Science to Evidence-based Medicine
  21. Probiotic monotherapy andHelicobacter pylorieradication: A systematic review with pooled-data analysis
  22. Letter: dose-response analysis revealed closer relationship between obesity and perioperative outcomes in patients after liver transplantation-Authors’ reply
  23. Hepatitis C Virus Clearance in Older Adults
  24. Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn’s Disease: A Systematic Review of Randomized Trials
  25. Influence of chemotherapy on total energy expenditure in patients with gastrointestinal cancer: A pilot study
  26. Obesity as predictor of postoperative outcomes in liver transplant candidates: Review of the literature and future perspectives
  27. HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study
  28. Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease
  29. A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study
  30. Editorial: liver transplantation in patients with non-alcoholic fatty liver disease and obesity-authors’ reply
  31. Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study
  32. Systematic review with meta-analysis: post-operative complications and mortality risk in liver transplant candidates with obesity
  33. Epstein-Barr Virus-Related Hyperacute Hepatitis: May Intravenous Steroids be an Effective Approach?
  34. Sequential Therapy For Helicobacter pylori in Elderly Patients: Effectiveness, Safety and Predictors of Success
  35. Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis
  36. Letter: can transient elastography and body mass index predict fibrosis regression in HBV patients on long-term nucleoside therapy?
  37. Update on the Medical Management of Gastrointestinal Behçet’s Disease
  38. Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: what needs to be explored?
  39. Noninvasive molecular analysis ofHelicobacter pylori: Is it time for tailored first-line therapy?
  40. Helicobacter pylori, liver cirrhosis, and portal hypertension: an updated appraisal
  41. Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients?
  42. Helicobacter pyloriDNA isolation in the stool: an essential pre-requisite for bacterial noninvasive molecular analysis
  43. Prognostic role of 25-hydroxyvitamin D in patients with liver metastases from colorectal cancer treated with radiofrequency ablation
  44. Lovastatin, but not orlistat, reduces intestinal polyp volume in an ApcMin/+ mouse model
  45. Acute pancreatitis in elderly patients: A retrospective evaluation at hospital admission
  46. Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis
  47. Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma
  48. May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis?
  49. Role of concomitant therapy forHelicobacter pylorieradication: A technical note
  50. Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association
  51. Multistage vector delivery of sulindac and silymarin for prevention of colon cancer
  52. Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients
  53. Medical Systemic Therapies for Hepatocellular Carcinoma: Clinical Perspectives and Safety Profile
  54. Seronegative Celiac Disease and Immunoglobulin Deficiency: Where to Look in the Submerged Iceberg?
  55. Polidocanol injection decreases the bleeding rate after colon polypectomy: a propensity score analysis
  56. A comparison of the nutritional status between adult celiac patients on a long-term, strictly gluten-free diet and healthy subjects
  57. Combination Therapy With Sorafenib and Radiofrequency Ablation for Hepatocellular Carcinoma: A Glimmer of Light after the Storm Trial?
  58. MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma
  59. Neurophysiologic and Psychometric Tests in the Diagnosis of Low-Grade Encephalopathy
  60. Biologic drugs in rheumatologic patients who experienced HBV infection
  61. Letter: prognostic scoring systems for hepatocellular carcinoma patients - the jury is still out
  62. Liver stiffness and portal blood flow modifications induced by a liquid meal consumption: pathogenetic mechanisms and clinical relevance
  63. Conditional survival analysis of hepatocellular carcinoma patients treated with radiofrequency ablation
  64. Endothelial Dysfunction Correlates with Liver Fibrosis in Chronic HCV Infection
  65. Echoendoscopic ethanol ablation of tumor combined to celiac plexus neurolysis improved pain control in a patient with pancreatic adenocarcinoma
  66. Non-polypoid colorectal neoplasms: Classification, therapy and follow-up
  67. Role of Bone Marrow-Derived Stem Cells in Polyps Development in Mice with ApcMin/+Mutation
  68. Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients
  69. Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation
  70. Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation
  71. An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C
  72. Transient GFER knockdown in vivo impairs liver regeneration after partial hepatectomy
  73. Olive oil and omega-3 polyunsaturated fatty acids suppress intestinal polyp growth by modulating the apoptotic process in ApcMin/+ mice
  74. Bone marrow-derived stem cells and hepatocarcinogenesis in hepatitis B virus transgenic mice
  75. Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin
  76. Ulcerative colitis: From inflammation to cancer. Do estrogen receptors have a role?
  77. HBsAg clearance by Peg-interferon addition to a long-term nucleos(t)ide analogue therapy
  78. Role of vaptans in the management of hydroelectrolytic imbalance in liver cirrhosis
  79. Variation in genes encoding for interferon λ-3 and λ-4 in the prediction of HCV-1 treatment-induced viral clearance
  80. Influence of Age and Type of Underlying Disease on Complications Related to Home Enteral Nutrition
  81. Disseminated tumour cells in bone marrow in experimental colon cancer: metastatic or resident?
  82. Estrogen Receptor beta in Colorectal Cancer Prevention: Do we have Conclusive Proof?
  83. Altered molecular pattern of mucosal healing in Crohn’s disease fibrotic stenosis
  84. Phytoestrogens/insoluble fibers and colonic estrogen receptor β: Randomized, double-blind, placebo-controlled study
  85. Lesson from an intriguing case of cryoglobulinemia
  86. Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit
  87. Estrogen receptors expression in long-lasting ulcerative pancolitis with and without dysplasia: A preliminary report
  88. Phytoestrogens as Nutritional Modulators in Colon Cancer Prevention
  89. Erratum to: Dietary, Endocrine, and Metabolic Factors in the Development of Colorectal Cancer
  90. Dietary, Endocrine, and Metabolic Factors in the Development of Colorectal Cancer
  91. Anti-Viral Therapy in Chronic HBV Infection: A Single Centre Experience
  92. Donor Risk Index and MELD Score Interactions in Graft Survival Prediction after Liver Transplantation. An Analysis of the OPTN-UNOS Database
  93. Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury
  94. ERβ expression in normal, adenomatous and carcinomatous tissues of patients with familial adenomatous polyposis
  95. Dietary-induced ER  upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice
  96. androgens and hepatocarcinoma
  97. Effect of gonadectomy on HCC development in HBV transgenic mice
  98. ER-β expression in large bowel adenomas: Implications in colon carcinogenesis
  99. Estrogens, phytoestrogens and colorectal neoproliferative lesions
  100. ABO Blood Group-Related Waiting List Disparities in Liver Transplant Candidates: Effect of the MELD Adoption
  101. Allocation of Nonstandard Livers to Transplant Candidates With High MELD Scores: Should This Practice Be Continued?
  102. ALLOCATION OF NON-STANDARD LIVERS TO LIVER TRANSPLANT CANDIDATES WITH HIGH MELD VALUES: SHOULD THIS PRACTICE BE CONTINUED?
  103. Use of “O” Blood Group Liver Donors for Nonidentical Recipients: Does This Represent a Double Penalty for “O” Blood Group Candidates?
  104. Estrogen-Induced Proliferation in Cultured Hepatocytes Involves Cyclin D1, P21CIP1 and P27KIP1
  105. Functional modification of CD11c+ liver dendritic cells during liver regeneration after partial hepatectomy in mice
  106. Sliding gastric hiatal hernia diagnosis by transabdominal ultrasonography: An easy, reliable and non-invasive procedure
  107. P.044 Organ specific gene expression profile reflect distinguished pathogenesis in liver and kidney during HBV persistence — a study in HBV transgenic mouse model
  108. Small Intestinal Contrast Ultrasonography-Based Scoring System
  109. Detection of Alkaline Sphingomyelinase Activity in Human Stool: Proposed Role as a New Diagnostic and Prognostic Marker of Colorectal Cancer
  110. Hepatitis D–related Cirrhosis and Risk of Hepatocellular Carinoma Development
  111. Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure
  112. Mycophenolate mofetil in the treatment of autoimmune HCV-associated haematological disorders showing steroid resistance or dependence
  113. Influence of ursodeoxycholate-enriched diet on liver tumor growth in HBV transgenic mice
  114. Second harmonic imaging improves trans-abdominal ultrasound detection of biliary sludge in ‘idiopathic’ pancreatitis
  115. Tumor Necrosis Factor Alpha and Apoptosis in Helicobacter pylori Related Progressive Gastric Damage: A Possible Mechanism of Immune System Involvement in Epithelial Turnover Regulation
  116. Demonstration of a Direct Stimulatory Effect of Bile Salts on Rat Colonic Epithelial Cell Proliferation
  117. Augmenter of liver regeneration is a mitochondrial sulfhydryl oxidase
  118. Analysis of individual items of mini-mental state examination in discrimination between normal and demented subjects
  119. Modulation of rat hepatocyte proliferation by bile salts: In vitro and In vivo studies
  120. Small-for-size liver transplanted into larger recipient: A model of hepatic regeneration
  121. Small-for-size liver transplanted into larger recipient: A model of hepatic regeneration
  122. Hepatic stimulatory substance (HSS) in liver regeneration
  123. Effect of Epomediol on Taurocholate Uptake in Hepatocytes Isolated from Normal Rats or Rats with Ethinyloestradiol-Induced Cholestasis
  124. Hepatic regeneration and growth factors
  125. Studies in vitro on the influence of ursodeoxycholate sodium salt (UDC) on hepatocyte proliferation
  126. Screening for candidate hepatic growth factors by selective portal infusion after canine Eck's fistula
  127. Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506
  128. Further steps of hepatic stimulatory substance purification
  129. Relationship between plasma and hepatic cytosolic levels of ornithine decarboxylase (ODC) and thymidine kinase (TK) in 70% hepatectomized rats
  130. Effect of ranitidine on acetaminophen-induced hepatotoxicity in dogs
  131. AUGMENTATION OF RAT LIVER REGENERATION BY FK 506 COMPARED WITH CYCLOSPORIN
  132. Estradiol and testosterone levels in patients undergoing partial hepatectomy
  133. Psychomotor dysfunctions in alcoholic and post-necrotic cirrhotic patients without overt encephalopathy
  134. The effect of estrogen and tamoxifen on hepatocyte proliferationin Vivo andin Vitro
  135. A Dog Model for Acetaminophen-Induced Fulminant Hepatic Failure
  136. Effect of cimetidine, ranitidine, famotidine and omeprazole on hepatocyte proliferation in vitro
  137. Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissue
  138. Effect of spironolactone and potassium canrenoate on cytosolic and nuclear androgen and estrogen receptors of rat liver